Updated Jul 16, 2026
Krognes Steve E. has filed 7 SEC Form 4 filings across 3 companies in the last 90 days — selling. Lifetime open-market sales: $2.10M.
Steve E. Krognes is a corporate director known for his roles at Guardant Health, Inc. and Denali Therapeutics Inc. He has participated in multiple SEC filings, indicating active involvement in corporate governance.
| Role | Director |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-02 | GH | Guardant Health, Inc. | M — Option exercise | 155 | $0.00 | |
| 2026-06-22 | GH | Guardant Health, Inc. | M — Option exercise | 4.2K | $0.00 | |
| 2026-06-05 | GH | Guardant Health, Inc. | S — Open-market sale | 9.3K | $132.51 | $1.23M |
| 2026-06-05 | DNLI | Denali Therapeutics Inc. | A — Grant or award | 6.4K | $0.00 | |
| 2026-06-01 | GH | Guardant Health, Inc. | M — Option exercise | 154 | $0.00 | |
| 2026-05-01 | GH | Guardant Health, Inc. | M — Option exercise | 154 | $0.00 | |
| 2026-04-01 | GH | Guardant Health, Inc. | M — Option exercise | 155 | $0.00 | |
| 2026-03-02 | GH | Guardant Health, Inc. | M — Option exercise | 154 | $0.00 | |
| 2026-02-02 | GH | Guardant Health, Inc. | M — Option exercise | 154 | $0.00 | |
| 2025-09-30 | GH | Guardant Health, Inc. | M — Option exercise | 154 | $0.00 | |
| 2025-08-31 | GH | Guardant Health, Inc. | M — Option exercise | 155 | $0.00 | |
| 2025-07-31 | GH | Guardant Health, Inc. | M — Option exercise | 154 | $0.00 | |
| 2025-06-30 | GH | Guardant Health, Inc. | M — Option exercise | 154 | $0.00 | |
| 2024-12-02 | GH | Guardant Health, Inc. | M — Option exercise | 154 | $0.00 | |
| 2024-11-04 | GH | Guardant Health, Inc. | M — Option exercise | 154 | $0.00 | |
| 2024-10-02 | DNLI | Denali Therapeutics Inc. | S — Open-market sale [10b5-1] | 30.0K | $29.03 | $871K |
| 2024-10-01 | GH | Guardant Health, Inc. | M — Option exercise | 154 | $0.00 |
Steve E. Krognes is a corporate director known for his roles at Guardant Health, Inc. and Denali Therapeutics Inc. He has participated in multiple SEC filings, indicating active involvement in corporate governance.…
7 primary Form 4 filings in the last 90 days, covering 3 companies.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($2.10M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Krognes Steve E. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.